Oncology Sponsored Patient Centricity to Integration: Enhancing Cancer Outcomes We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
News EC clears first treatment for high-risk smouldering multiple... Johnson & Johnson’s Janssen-Cilag has secured European Commission approval for a new indication of its subcutaneous formulation of DARZALEX
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face